Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Zevra Therapeutics Inc (ZVRA)

144 + Investors. Track Smart Money conviction in ZVRA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -10
Streak
2Q ▼
Buyers last Q
49%

Smart Money Signals — ZVRA

Based on 145 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their ZVRA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 90% of 3.0Y peak

90% of all-time peak
145 funds currently hold this stock — 90% of the 3.0-year high of 161 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q
+35 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 49% buying

79 buying82 selling
Last quarter: 82 funds reduced or exited vs 79 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~20 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 23 → 53 → 23 → 20. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 34% medium ■ 26% new
59 out of 145 hedge funds have held ZVRA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

17 → 23 → 53 → 23 → 20 new funds/Q
New funds entering each quarter: 23 → 53 → 23 → 20. ZVRA is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 49% of holders stayed 2+ years

■ 49% veterans ■ 18% 1-2yr ■ 33% new
Of 155 current holders: 76 (49%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
40 of 145 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ZVRA

In 2026 Q1, 79 hedge funds were net buyers of ZVRA (20 opened a new position, 59 added to an existing one), while 82 reduced or exited (52 trimmed, 30 sold completely) — a 49% buyer ratio, indicating roughly balanced activity. Net selling has persisted for two consecutive quarters. 36% of total institutional value in ZVRA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -10 funds (more exits than new entries). Total institutional holders: 145.

Hedge Fund Ownership: ZVRA

How many hedge funds hold ZVRA — quarterly history vs. share price
Quarterly hedge fund ownership of ZVRA vs. share price

Market Analysis: ZVRA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ZVRA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Zevra Therapeutics Inc (ZVRA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ZVRA has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
ZVRA
+35.7%
XLV
+4.9%

ZVRA outperformed XLV by +30.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
ZVRA
+14.9%
XLV
+6.0%

Since the filing became public, ZVRA outperformed XLV by +8.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

18 top-rated funds 0 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: ZVRA
144 + Investors

Track Smart Money conviction in ZVRA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 144 155 -7.1%
13F Shares 44M 41M 7.33%
Total Value $409M $369M 10.88%
New Positions 19 23 -4
Increased Positions 55 60 -5
Closed Positions 30 29 +1
Reduced Positions 50 50 -
Total Calls 6 7 -14.29%
Total Puts 4 4 -
PUT/CALL Ratio 0.67 0.57 Bullish

Statistics: ZVRA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

144 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ZVRA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ZVRA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Retirement Planning Co of New England, Inc. 2.47% 651,148 $6.1M
2 Stonepine Capital Management, LLC 1.79% 480,000 $4.5M
3 Propel Bio Management, LLC 1.66% 282,418 $2.6M
4 AIGH Capital Management LLC 1.53% 1,200,000 $11.2M
5 Nantahala Capital Management, LLC 0.87% 2,521,936 $23.5M
6 Kingdon Capital Management, L.L.C. 0.79% 775,000 $7.2M
7 Mystic Asset Management, Inc. 0.78% 361,283 $3.4M
8 683 Capital Management, LLC 0.47% 975,000 $9.1M
9 Diametric Capital, LP 0.26% 108,024 $1.0M
10 Phocas Financial Corp. 0.23% 159,423 $1.5M
11 Woodline Partners LP 0.12% 3,450,943 $32.2M
12 EntryPoint Capital, LLC 0.12% 42,885 $400K
13 Caption Management, LLC 0.11% 2,002,800 $18.7M
14 IFG Advisors, LLC 0.09% 61,842 $576K
15 Royce & Associates LP 0.09% 988,674 $9.2M
16 Kovack Advisors, Inc. 0.09% 175,232 $1.6M
17 Integrated Quantitative Investments LLC 0.06% 33,315 $310K
18 Hennion & Walsh Asset Management, Inc. 0.06% 177,163 $1.7M
19 Carret Asset Management, LLC 0.05% 59,500 $555K
20 Flputnam Investment Management Co 0.05% 350,501 $3.3M
21 Arete Wealth Advisors, LLC 0.05% 66,397 $617K
22 Stratos Wealth Partners, LTD. 0.04% 408,000 $3.8M
23 City State Bank 0.04% 15,478 $144K
24 DGS Capital Management, LLC 0.02% 14,810 $138K
25 Prelude Capital Management, LLC 0.02% 25,941 $242K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Zevra Therapeutics Inc (ZVRA)

What does the Smart Money Trend signal show for ZVRA?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their ZVRA positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ZVRA?

More sellers than buyers — 49% buying: Last quarter: 82 funds reduced or exited vs 79 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for ZVRA holders?

Strong quality — 36% AUM from major funds: 40 of 145 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ZVRA?

41% of holders stayed for 2+ years: 59 out of 145 hedge funds have held ZVRA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Zevra Therapeutics Inc (ZVRA) following the 2026 Q1 hedge fund 13F filings?

As of today, ZVRA has moved +14.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +8.9%. Since the quarter end (March 31, 2026), ZVRA has gained +35.7% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →